National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Interventional Fluoroscopy: Reducing Radiation Risks for Patients and Staff
    Posted: 04/18/2005



Introduction






Increasing use and complexity






Determinants of radiation dose






Radiation risks






Strategies to optimize radiation exposure






Physician-patient communication before and after






Dosimetry records and follow up






Education and training






Conclusion






Reference list



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Dosimetry records and follow up

Measure & record patient radiation dose:
  • Record fluoroscopy time
  • Record available measures - DAP (dose area product), cumulative dose, skin dose

Inform patients who have received high doses to examine the x-ray beam entrance site for skin erythema

 

Develop methods to quantify late effects:
  • Design medical records to clearly document the number and types of interventional procedures received by the patient
  • Maintain a database of all patients with procedure and dose information
  • Review dose information to identify patients with high doses (>2Gy) for follow up
  • Establish procedures for follow-up, including skin examination at 30 days

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov